Thomas M. Gorter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas M. Gorter has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
Dirk J. van Veldhuisen
University Medical Centre Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands
17 shared publicationsMichiel Rienstra
University Medical Centre Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands
9 shared publicationsAdriaan A. Voors
University Medical Centre Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands
7 shared publicationsElke S. Hoendermis
Department of Cardiology, University Medical Center Groningen, University of Groningen , Hanzeplein 1, PO Box 30.001, Groningen
7 shared publicationsJoost P. van Melle
Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
7 shared publications- Dirk Jan van Veldhuisen
Department of Cardiology, University Medical Centre Groningen, University of Groningen, the Netherlands (D.J.v.V.).
6 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Netherlands Heart Journal
- p. 1
Correction to: Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
- 3 November 2026
- Published by Springer Nature in Netherlands Heart Journal
- p. 1
Open AccessCorrection to: Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
- Open Access
- 16 September 2026
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 34 (10) , 369-379
Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
Background: Central obesity, rather than overall obesity, may influence heart failure (HF) outcomes. Alternative anthropometric measures remain limited in assessing the actual amount and distribution of visceral adiposity. We hypothesize that epicardial and pericardial adipose tissue (EAT and PAT) are easily obtainable on standard echocardiography and provide prognostic value in patients with HF. Methods: In total, 572 patients with HF with reduced, mildly reduced and preserved ejection fraction (HFrEF, HFmrEF, and HFpEF, respectively) were included. EAT (the adipose tissue between the myocardium and the visceral layer of the pericardium) and PAT (the adipose tissue outside the parietal layer of the pericardium) thickness were measured on echocardiography and expressed in mm. Patients were followed for the combined outcome of all-cause mortality and HF hospitalization. Results: Mean age was 67 ± 14 years, 38% were women, 346 had HFrEF, 100 had HFmrEF and 126 had HFpEF. Mean body mass index (BMI) was 27 ± 6 kg/m 2 , mean EAT thickness 4.8 ± 2.1 mm, and mean PAT thickness 5.7 ± 2.8 mm. During a median follow-up of 3.2 ± 1.9 years, both EAT and PAT thickness were associated with an increased risk for the combined outcome [HR 1.15 (95% CI 1.03–1.30), p = 0.006 and HR 1.25 (95% CI 1.10–1.41), p < 0.001, respectively], whereas BMI was not. In a multivariable model, only PAT thickness remained associated with poor outcome [HR 1.49 per SD (95% CI 1.10–2.03), p = 0.011]. Conclusion: Increased PAT thickness, more than EAT, assessed on routine echocardiography, may serve as a valuable prognostic marker in chronic HF.
- 16 September 2026
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 34 (10) , 369-379
Open AccessPrognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
Background: Central obesity, rather than overall obesity, may influence heart failure (HF) outcomes. Alternative anthropometric measures remain limited in assessing the actual amount and distribution of visceral adiposity. We hypothesize that epicardial and pericardial adipose tissue (EAT and PAT) are easily obtainable on standard echocardiography and provide prognostic value in patients with HF. Methods: In total, 572 patients with HF with reduced, mildly reduced and preserved ejection fraction (HFrEF, HFmrEF, and HFpEF, respectively) were included. EAT (the adipose tissue between the myocardium and the visceral layer of the pericardium) and PAT (the adipose tissue outside the parietal layer of the pericardium) thickness were measured on echocardiography and expressed in mm. Patients were followed for the combined outcome of all-cause mortality and HF hospitalization. Results: Mean age was 67 ± 14 years, 38% were women, 346 had HFrEF, 100 had HFmrEF and 126 had HFpEF. Mean body mass index (BMI) was 27 ± 6 kg/m 2 , mean EAT thickness 4.8 ± 2.1 mm, and mean PAT thickness 5.7 ± 2.8 mm. During a median follow-up of 3.2 ± 1.9 years, both EAT and PAT thickness were associated with an increased risk for the combined outcome [HR 1.15 (95% CI 1.03–1.30), p = 0.006 and HR 1.25 (95% CI 1.10–1.41), p < 0.001, respectively], whereas BMI was not. In a multivariable model, only PAT thickness remained associated with poor outcome [HR 1.49 per SD (95% CI 1.10–2.03), p = 0.011]. Conclusion: Increased PAT thickness, more than EAT, assessed on routine echocardiography, may serve as a valuable prognostic marker in chronic HF.
- Open Access
- 4 September 2026
- Published by Elsevier in Journal of Cardiac Failure
Body Composition in Heart Failure: A Phenotype-Informed Framework for Assessment and Management
- 4 September 2026
- Published by Elsevier in Journal of Cardiac Failure
Open AccessBody Composition in Heart Failure: A Phenotype-Informed Framework for Assessment and Management
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Response to the letter to the editor: Epicardial, visceral and subcutaneous adipose tissue in heart failure with preserved ejection fraction
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Open AccessResponse to the letter to the editor: Epicardial, visceral and subcutaneous adipose tissue in heart failure with preserved ejection fraction
- Open Access
- 9 March 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
- Vol. 2 (4) , 305-307
Epicardial Adipose Tissue and Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction: Challenging a Complex Conundrum
- 9 March 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
- Vol. 2 (4) , 305-307
Open AccessEpicardial Adipose Tissue and Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction: Challenging a Complex Conundrum
- Open Access
- 8 January 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (1)
Visual scoring of bone scintigraphy in ATTR-CM: insights from the TTRACK study
- 8 January 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (1)
Open AccessVisual scoring of bone scintigraphy in ATTR-CM: insights from the TTRACK study
- Open Access
- 21 August 2025
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 60, 101775
Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
- 21 August 2025
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 60, 101775
Open AccessCarbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction